Search Clinical Trials
585,525 trials
ID
Status
Phase
Title
Sponsor
NCT07598643
Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1Anschutz Acceleration InitiativeRecruitingPhase 2
NCT07598643Recruiting
Phase 2
Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neuro...Anschutz Acceleration Ini...
NCT07599917
Diagnostic Performance and Quantitative Analysis of [18F]FET PET in Brain TumoursIRCCS San RaffaeleNot Yet Recruiting
NCT07599917Not Yet Recruiting
—
Diagnostic Performance and Quantitative Analysis of [18F]FET PET in Brain Tumour...IRCCS San Raffaele
NCT07599553
Study of Feasibility for Surgical Patients Undergoing Heart Surgery With the Mammary Arteries: Reviewing Infection, Occlusion Rates and Pain Assessments.Ottawa Heart Institute Research CorporationNot Yet RecruitingNot Applicable
NCT07599553Not Yet Recruiting
Not Applicable
Study of Feasibility for Surgical Patients Undergoing Heart Surgery With the Mam...Ottawa Heart Institute Re...
NCT07598903
Pharmacy-based Opportunistic Atrial Fibrillation Screening Integrated With Emergency Services (NUMAPLUS-FA)Andalusian Regional Ministry of HealthNot Yet Recruiting
NCT07598903Not Yet Recruiting
—
Pharmacy-based Opportunistic Atrial Fibrillation Screening Integrated With Emerg...Andalusian Regional Minis...
NCT07598305
PICN Versus Bioactive Composite for Cervical Restorations in Ballet DancersI.M. Sechenov First Moscow State Medical UniversityCompletedNot Applicable
NCT07598305Completed
Not Applicable
PICN Versus Bioactive Composite for Cervical Restorations in Ballet DancersI.M. Sechenov First Mosco...
NCT07600151
Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple MyelomaAbbVieNot Yet RecruitingPhase 1
NCT07600151Not Yet Recruiting
Phase 1
Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple MyelomaAbbVie
NCT07598890
Phase I Clinical Trial of Adsorbed Tetanus VaccineAimei Vacin BioPharm (Zhejiang) Co., Ltd.Not Yet RecruitingPhase 1
NCT07598890Not Yet Recruiting
Phase 1
Phase I Clinical Trial of Adsorbed Tetanus VaccineAimei Vacin BioPharm (Zhe...
NCT07598032
Comparative Analysis of Immunological Responses to Vitamin D Replacement Therapy in Black and West African Men Diagnosed With Prostate Cancer: Elucidating Differential Effects on Immune Function Between Patients With Localized Disease and Those With Metastatic ProgressionMayo ClinicNot Yet RecruitingPhase 3
NCT07598032Not Yet Recruiting
Phase 3
Comparative Analysis of Immunological Responses to Vitamin D Replacement Therapy...Mayo Clinic
NCT07600320
Fareon Open Label Device Clinical TrialIcahn School of Medicine at Mount SinaiNot Yet RecruitingNot Applicable
NCT07600320Not Yet Recruiting
Not Applicable
Fareon Open Label Device Clinical TrialIcahn School of Medicine...
NCT07599735
The Feasibility and Acceptability of a Collaborative Deprescribing Intervention to Reduce Anticholinergic Burden Among Hospitalised Older PatientsUniversity of SouthamptonCompleted
NCT07599735Completed
—
The Feasibility and Acceptability of a Collaborative Deprescribing Intervention...University of Southampton
NCT07599657
Surfactant Protein D Levels in GCF Before and After MINST in PeriodontitisCairo UniversityRecruitingNot Applicable
NCT07599657Recruiting
Not Applicable
Surfactant Protein D Levels in GCF Before and After MINST in PeriodontitisCairo University
NCT07599592
Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential TremorUniversity of California, Los AngelesRecruitingEarly Phase 1
NCT07599592Recruiting
Early Phase 1
Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential T...University of California,...
NCT07600528
A Exploratory Study of NatureU Sweet Dream on Sleep OutcomesOmniSolutions Laboratory Holdings LimitedCompletedNot Applicable
NCT07600528Completed
Not Applicable
A Exploratory Study of NatureU Sweet Dream on Sleep OutcomesOmniSolutions Laboratory...
NCT07600164
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast CancerPeking University People's HospitalNot Yet RecruitingPhase 4
NCT07600164Not Yet Recruiting
Phase 4
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Brea...Peking University People'...
NCT07600307
Evaluating a Digital Toolkit for IPVMedical University of South CarolinaNot Yet RecruitingNot Applicable
NCT07600307Not Yet Recruiting
Not Applicable
Evaluating a Digital Toolkit for IPVMedical University of Sou...
NCT07598396
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus NephritisHoffmann-La RocheRecruitingPhase 2
NCT07598396Recruiting
Phase 2
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythemato...Hoffmann-La Roche
NCT07598708
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of HypersomnolenceCentessa Pharmaceuticals (UK) LimitedNot Yet RecruitingPhase 2
NCT07598708Not Yet Recruiting
Phase 2
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the...Centessa Pharmaceuticals...
NCT07598110
FLUDARABINE-TREOSULFAN REDUCED INTENSITY CONDITIONING REGIMEN PRIOR HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST TRANSPLANTATION CYCLOPHOSPHAMIDE FOR OLDER AND/OR FRAIL PATIENTS WITH AMLInstitut Paoli-CalmettesNot Yet RecruitingPhase 2
NCT07598110Not Yet Recruiting
Phase 2
FLUDARABINE-TREOSULFAN REDUCED INTENSITY CONDITIONING REGIMEN PRIOR HAPLOIDENTIC...Institut Paoli-Calmettes
NCT07600268
Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic CancerShandong Cancer Hospital and InstituteRecruitingPhase 2
NCT07600268Recruiting
Phase 2
Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Ther...Shandong Cancer Hospital...
NCT07599930
Impact of a Novel Functional Snack on Perimenopausal Symptoms and Well-beingKing's College LondonRecruitingNot Applicable
NCT07599930Recruiting
Not Applicable
Impact of a Novel Functional Snack on Perimenopausal Symptoms and Well-beingKing's College London
Result Breakdown
Not yet recruiting11 (55%)
Recruiting6 (30%)
Completed3 (15%)
not_applicable7 (35%)
Phase 25 (25%)
Not Specified3 (15%)
Phase 12 (10%)
Phase 31 (5%)
Early Phase 11 (5%)
Phase 41 (5%)